NBSE
Vanguard Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,981
| Closed | -$8.54K | – | 4484 |
|
|
2024
Q1 | $8.54K | Hold |
18,981
| – | – | ﹤0.01% | 4432 |
|
|
2023
Q4 | $14K | Hold |
18,981
| – | – | ﹤0.01% | 4465 |
|
|
2023
Q3 | $16.5K | Hold |
18,981
| – | – | ﹤0.01% | 4508 |
|
|
2023
Q2 | $35.5K | Sell |
18,981
-357,777
| -95% | -$669K | ﹤0.01% | 4491 |
|
|
2023
Q1 | $69.7K | Sell |
376,758
-568,916
| -60% | -$105K | ﹤0.01% | 4435 |
|
|
2022
Q4 | $180K | Sell |
945,674
-113,380
| -11% | -$21.6K | ﹤0.01% | 4327 |
|
|
2022
Q3 | $419K | Hold |
1,059,054
| – | – | ﹤0.01% | 4262 |
|
|
2022
Q2 | $1.11M | Hold |
1,059,054
| – | – | ﹤0.01% | 4052 |
|
|
2022
Q1 | $1.99M | Sell |
1,059,054
-305,580
| -22% | -$574K | ﹤0.01% | 3960 |
|
|
2021
Q4 | $3.83M | Sell |
1,364,634
-1,696
| -0.1% | -$4.77K | ﹤0.01% | 3758 |
|
|
2021
Q3 | $4.93M | Buy |
1,366,330
+68,482
| +5% | +$247K | ﹤0.01% | 3671 |
|
|
2021
Q2 | $6.22M | Buy |
1,297,848
+339,017
| +35% | +$1.62M | ﹤0.01% | 3476 |
|
|
2021
Q1 | $7.09M | Buy |
958,831
+33,930
| +4% | +$251K | ﹤0.01% | 3350 |
|
|
2020
Q4 | $6.47M | Buy |
924,901
+8,348
| +0.9% | +$58.4K | ﹤0.01% | 3221 |
|
|
2020
Q3 | $6.96M | Buy |
916,553
+787,965
| +613% | +$5.98M | ﹤0.01% | 2982 |
|
|
2020
Q2 | $1.13M | Buy |
128,588
+87,491
| +213% | +$768K | ﹤0.01% | 3581 |
|
|
2020
Q1 | $293K | Hold |
41,097
| – | – | ﹤0.01% | 3796 |
|
|
2019
Q4 | $296K | Hold |
41,097
| – | – | ﹤0.01% | 3881 |
|
|
2019
Q3 | $205K | Buy |
41,097
+14,500
| +55% | +$72.3K | ﹤0.01% | 3958 |
|
|
2019
Q2 | $91K | Hold |
26,597
| – | – | ﹤0.01% | 4059 |
|
|
2019
Q1 | $60K | Sell |
26,597
-505,334
| -95% | -$1.14M | ﹤0.01% | 4051 |
|
|
2018
Q4 | $46K | Sell |
531,931
-1,360,705
| -72% | -$118K | ﹤0.01% | 4078 |
|
|
2018
Q3 | $350K | Hold |
1,892,636
| – | – | ﹤0.01% | 3909 |
|
|
2018
Q2 | $371K | Sell |
1,892,636
-35,885
| -2% | -$7.03K | ﹤0.01% | 3876 |
|
|
2018
Q1 | $424K | Buy |
1,928,521
+296,896
| +18% | +$65.3K | ﹤0.01% | 3817 |
|
|
2017
Q4 | $3.04M | Buy |
1,631,625
+503,394
| +45% | +$936K | ﹤0.01% | 3301 |
|
|
2017
Q3 | $812K | Buy |
1,128,231
+315,813
| +39% | +$227K | ﹤0.01% | 3642 |
|
|
2017
Q2 | $520K | Buy |
812,418
+5,481
| +0.7% | +$3.51K | ﹤0.01% | 3720 |
|
|
2017
Q1 | $670K | Buy |
806,937
+23,886
| +3% | +$19.8K | ﹤0.01% | 3687 |
|
|
2016
Q4 | $1.18M | Sell |
783,051
-139,565
| -15% | -$209K | ﹤0.01% | 3511 |
|
|
2016
Q3 | $2.61M | Hold |
922,616
| – | – | ﹤0.01% | 3294 |
|
|
2016
Q2 | $2.53M | Buy |
922,616
+9,763
| +1% | +$26.8K | ﹤0.01% | 3286 |
|
|
2016
Q1 | $2.93M | Buy |
912,853
+111,818
| +14% | +$359K | ﹤0.01% | 3220 |
|
|
2015
Q4 | $4.92M | Buy |
801,035
+76,214
| +11% | +$468K | ﹤0.01% | 2991 |
|
|
2015
Q3 | $2M | Buy |
724,821
+109,397
| +18% | +$302K | ﹤0.01% | 3376 |
|
|
2015
Q2 | $1.55M | Buy |
615,424
+6,722
| +1% | +$16.9K | ﹤0.01% | 3520 |
|
|
2015
Q1 | $1.55M | Buy |
608,702
+48,418
| +9% | +$123K | ﹤0.01% | 3498 |
|
|
2014
Q4 | $4.67M | Buy |
560,284
+16,796
| +3% | +$140K | ﹤0.01% | 2934 |
|
|
2014
Q3 | $3.94M | Buy |
543,488
+45,236
| +9% | +$328K | ﹤0.01% | 2959 |
|
|
2014
Q2 | $4.74M | Buy |
498,252
+160,133
| +47% | +$1.52M | ﹤0.01% | 2861 |
|
|
2014
Q1 | $4.6M | Buy |
338,119
+271,033
| +404% | +$3.69M | ﹤0.01% | 2867 |
|
|
2013
Q4 | $529K | Buy |
67,086
+55,186
| +464% | +$435K | ﹤0.01% | 3580 |
|
|
2013
Q3 | $97K | Buy |
+11,900
| New | +$97K | ﹤0.01% | 3774 |
|